In the European markets, recent weeks have seen a dip in the STOXX Europe 600 Index amid geopolitical tensions and inflationary pressures driven by rising energy costs. Despite these challenges, robust earnings growth from many European companies highlights potential opportunities for investors seeking value stocks priced below their estimated worth.Identifying undervalued stocks often involves looking for companies with strong fundamentals that are temporarily overlooked by the market due to broader economic concerns.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| Waystream Holding (OM:WAYS) |
SEK41.40 |
SEK82.37 |
49.7% |
| Technip Energies (ENXTPA:TE) |
€35.66 |
€70.42 |
49.4% |
| Sdiptech (OM:SDIP B) |
SEK242.00 |
SEK479.64 |
49.5% |
| Revenio Group Oyj (HLSE:REG1V) |
€14.10 |
€27.99 |
49.6% |
| Netcompany Group (CPSE:NETC) |
DKK343.00 |
DKK682.13 |
49.7% |
| Micro Systemation (OM:MSAB B) |
SEK70.40 |
SEK139.63 |
49.6% |
| Hanza (OM:HANZA) |
SEK170.40 |
SEK335.43 |
49.2% |
| Demant (CPSE:DEMANT) |
DKK228.20 |
DKK454.98 |
49.8% |
| Cavotec Group (OM:CCC) |
SEK13.45 |
SEK26.71 |
49.7% |
| B&S Group (ENXTAM:BSGR) |
€5.85 |
€11.66 |
49.8% |
Here we highlight a subset of our preferred stocks from the screener.
Sparebanken Norge
Overview:Sparebanken Norge is a financial services company that offers banking and financing services, with a market cap of NOK33.07 billion.
Operations:Sparebanken Norge generates revenue through its banking and financing services.
Estimated Discount To Fair Value:36.8%
Sparebanken Norge is trading at NOK 190.92, significantly below its estimated future cash flow value of NOK 302.1, indicating potential undervaluation based on cash flows. Despite a history of shareholder dilution and an unstable dividend track record, the bank's earnings are forecast to grow significantly over the next three years, outpacing both revenue growth and Norwegian market averages. Recent fixed-income offerings enhance its liquidity position but highlight reliance on higher-risk funding sources.
Apotea
Overview:Apotea AB (publ) operates an online pharmacy in Sweden with a market cap of SEK7.91 billion.
Operations:The company's revenue is primarily derived from its online retail segment, amounting to SEK7.39 billion.
Estimated Discount To Fair Value:32.6%
Apotea is trading at SEK 76.05, well below its estimated future cash flow value of SEK 112.87, highlighting potential undervaluation. The company's earnings are projected to grow significantly at 21.6% annually, surpassing the Swedish market average growth rate of 8.4%. Recent first-quarter results showed increased sales and net income compared to last year, supporting a positive outlook despite slower revenue growth relative to high-growth benchmarks.
Sdiptech
Overview:Sdiptech AB (publ) offers technical services for infrastructures across various countries including Sweden, the United Kingdom, and the United States, with a market cap of SEK9.19 billion.
Operations:The company's revenue segments include Safety & Security (SEK439 million), Water & Bioeconomy (SEK897 million), Energy & Electrification (SEK1.11 billion), and Supply Chain & Transportation (SEK2.06 billion).
Estimated Discount To Fair Value:49.5%
Sdiptech, trading at SEK 242, is significantly undervalued with an estimated future cash flow value of SEK 479.64. Despite a challenging first quarter with net income dropping to SEK 14 million from SEK 71 million last year, the company is expected to achieve above-market profit growth over the next three years. However, interest payments are not well covered by earnings, and its revenue growth forecast of 4.6% per year remains modest compared to high-growth standards.
-
The growth report we've compiled suggests that Sdiptech's future prospects could be on the up.
-
Unlock comprehensive insights into our analysis of Sdiptech stock in this financial health report.
Seize The Opportunity
-
Reveal the 189 hidden gems among our Undervalued European Stocks Based On Cash Flows screener with a single click here.
-
Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
-
Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Ready To Venture Into Other Investment Styles?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OB:SBNOR OM:APOTEA and OM:SDIP B.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
